{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2017-N-0763\" sorted by posted_date descending", "rows": [["FDA-2017-N-0763-1452", "FDA", "FDA-2017-N-0763", "Letter from Antonio McGee to FDA DDM", "Other", "Letter(s)", "2019-02-22T05:00:00Z", 2019, 2, "2019-02-22T05:00:00Z", null, "2019-02-22T15:15:44Z", null, 0, 0, "0900006483a98e8d"], ["FDA-2017-N-0763-0867", "FDA", "FDA-2017-N-0763", "Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2018-01-17T05:00:00Z", 2018, 1, "2018-01-17T05:00:00Z", "2018-03-20T03:59:59Z", "2023-08-08T01:02:42Z", "2018-00683", 0, 0, "0900006482e18b55"], ["FDA-2017-N-0763-0568", "FDA", "FDA-2017-N-0763", "Request for Extension from Soyfoods Association of North America", "Other", "Request for Extension", "2018-01-02T05:00:00Z", 2018, 1, "2018-01-02T05:00:00Z", null, "2018-01-02T14:51:45Z", null, 0, 0, "0900006482d7f5ea"], ["FDA-2017-N-0763-0067", "FDA", "FDA-2017-N-0763", "Reference_64 van Raaij_1982_Influence of diets containing containing casein, soy isolate, and soy concentrate", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:37Z", null, 0, 0, "0900006482c14082"], ["FDA-2017-N-0763-0074", "FDA", "FDA-2017-N-0763", "Reference_77 Kurowska_1997_Effects of substituting dietary soybean protein and oil for milk protein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:39:24Z", null, 0, 0, "0900006482c142aa"], ["FDA-2017-N-0763-0099", "FDA", "FDA-2017-N-0763", "Reference_92 Wu_2005_A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:28Z", null, 0, 0, "0900006482c143b2"], ["FDA-2017-N-0763-0098", "FDA", "FDA-2017-N-0763", "Reference_93 Steele_The effect on serum cholesterol levels of substituting milk with a soya beverage", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:27Z", null, 0, 0, "0900006482c143b3"], ["FDA-2017-N-0763-0110", "FDA", "FDA-2017-N-0763", "Reference_101 Swain_2002_Iron indexes and total antioxidant status in responses to soy protein intake in perimenopausal", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:31Z", null, 0, 0, "0900006482c143f3"], ["FDA-2017-N-0763-0125", "FDA", "FDA-2017-N-0763", "Reference_126 D'Amico_1992_Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:27Z", null, 0, 0, "0900006482c14455"], ["FDA-2017-N-0763-0160", "FDA", "FDA-2017-N-0763", "Reference_151 Jenkins_2003_Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:00:38Z", null, 0, 0, "0900006482c144bb"], ["FDA-2017-N-0763-0156", "FDA", "FDA-2017-N-0763", "Reference_155 Jones_2005_Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:00:37Z", null, 0, 0, "0900006482c144bf"], ["FDA-2017-N-0763-0121", "FDA", "FDA-2017-N-0763", "Reference_110 Nilausen_1998_Variable lipemic response to dietary soy protein in healthy,normolipemic men", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:50:24Z", null, 0, 0, "0900006482c145ea"], ["FDA-2017-N-0763-0120", "FDA", "FDA-2017-N-0763", "Reference_111 Nilausen_1999_Lipoprotein(a) and dietary proteins-casein lowers lipoprotein(a) concentrations", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:50:24Z", null, 0, 0, "0900006482c145eb"], ["FDA-2017-N-0763-0145", "FDA", "FDA-2017-N-0763", "Reference_146 Zittermann-2004_Short-term effects of high soy. supplementation on sex hormones, bone markers", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:20Z", null, 0, 0, "0900006482c146ae"], ["FDA-2017-N-0763-0153", "FDA", "FDA-2017-N-0763", "Reference_158_NHLBI_2003_Seventh Report of the Joint National Committee on Prevention", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:00:36Z", null, 0, 0, "0900006482c146b3"], ["FDA-2017-N-0763-0229", "FDA", "FDA-2017-N-0763", "Reference_222 Yang_2005_Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:10:50Z", null, 0, 0, "0900006482c146db"], ["FDA-2017-N-0763-0223", "FDA", "FDA-2017-N-0763", "Reference_228 The ATBC cancer prevention study group._1994_The effect of vitamin E and beta carotene on the incidence", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:10:48Z", null, 0, 0, "0900006482c146e1"], ["FDA-2017-N-0763-0037", "FDA", "FDA-2017-N-0763", "Reference_34 Wong_1995_Cholesterol synthesis and absorption by 2h2o and 18o-cholesterol", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:16:45Z", null, 0, 0, "0900006482c13ffb"], ["FDA-2017-N-0763-0196", "FDA", "FDA-2017-N-0763", "Reference_195 Gardner_2001_The effect of soy protein with or without isoflavones relative to milk protein onplasma lipids", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:06:07Z", null, 0, 0, "0900006482c1493f"], ["FDA-2017-N-0763-0194", "FDA", "FDA-2017-N-0763", "Reference_197 Chen_2006_Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:06:06Z", null, 0, 0, "0900006482c14941"], ["FDA-2017-N-0763-0203", "FDA", "FDA-2017-N-0763", "Reference_208 Jenkins_2000_Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:07:44Z", null, 0, 0, "0900006482c14973"], ["FDA-2017-N-0763-0216", "FDA", "FDA-2017-N-0763", "Reference_215 Ho_2000_Intake of soy products is associated with better plasma lipid profiles", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:09:53Z", null, 0, 0, "0900006482c149be"], ["FDA-2017-N-0763-0018", "FDA", "FDA-2017-N-0763", "Reference_13 USDA_2016_Soy Milk,USDA National Nutrient Database for Standard Reference, 28", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:14:28Z", null, 0, 0, "0900006482c13fbf"], ["FDA-2017-N-0763-0015", "FDA", "FDA-2017-N-0763", "Reference_16 IOM_DRIs for Water, Potassium, Sodium, Chloride, and Sulfate", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:14:28Z", null, 0, 0, "0900006482c13fc2"], ["FDA-2017-N-0763-0060", "FDA", "FDA-2017-N-0763", "Reference_51 Potter_1976_Greater bile acid excretion with soy bean than with cow milk in infants", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:22:34Z", null, 0, 0, "0900006482c1423d"], ["FDA-2017-N-0763-0090", "FDA", "FDA-2017-N-0763", "Reference_81 Gaddi_1987_Hypercholesterolaemia treated by soybean protein diet", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:43:46Z", null, 0, 0, "0900006482c142ae"], ["FDA-2017-N-0763-0109", "FDA", "FDA-2017-N-0763", "Reference_102 Sirtori_Soy milk with a high glycitein content does not reduce low-density lipoprotein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:31Z", null, 0, 0, "0900006482c143f4"], ["FDA-2017-N-0763-0127", "FDA", "FDA-2017-N-0763", "Reference_124_Mercer_1987_Effects of human plasma lipids of substituting soybean protein isolate for milk protein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:27Z", null, 0, 0, "0900006482c14453"], ["FDA-2017-N-0763-0137", "FDA", "FDA-2017-N-0763", "Reference_134 Ham _1993_Endocrinological response to soy protein and fiber in mildly hypercholesterolemic men", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:08Z", null, 0, 0, "0900006482c14476"], ["FDA-2017-N-0763-0136", "FDA", "FDA-2017-N-0763", "Reference_135 Roughead_2005_Controlled substitution of soy protein for meat protein-effects on calcium retention, bone", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:08Z", null, 0, 0, "0900006482c14477"], ["FDA-2017-N-0763-0162", "FDA", "FDA-2017-N-0763", "Reference_169 Jayagopal_2002_Beneficial effects of soy phytoestrogen intake in postmenopausal women", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:02:06Z", null, 0, 0, "0900006482c144eb"], ["FDA-2017-N-0763-0151", "FDA", "FDA-2017-N-0763", "Reference_140 Liao_2007_Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:21Z", null, 0, 0, "0900006482c146a6"], ["FDA-2017-N-0763-0146", "FDA", "FDA-2017-N-0763", "Reference_145_Vigna_2000_Plasma lipoproteins in soy-treated postmenopausal women-a double-blind, placebo-controlled trial", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:20Z", null, 0, 0, "0900006482c146ab"], ["FDA-2017-N-0763-0166", "FDA", "FDA-2017-N-0763", "Reference_165 McVeigh_2006_Effect of soy protein varying in isoflavone content on serum lipids", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:02:07Z", null, 0, 0, "0900006482c146ba"], ["FDA-2017-N-0763-0173", "FDA", "FDA-2017-N-0763", "Reference_178 Takatsuka_2000_Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:03:25Z", null, 0, 0, "0900006482c14919"], ["FDA-2017-N-0763-0011", "FDA", "FDA-2017-N-0763", "Reference Index", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:11:40Z", null, 0, 0, "0900006482c13ba7"], ["FDA-2017-N-0763-0005", "FDA", "FDA-2017-N-0763", "Reference_06 NRC_2011_Reference Manual on Scientific Evidence Third Edition", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:11:39Z", null, 0, 0, "0900006482c13f9a"], ["FDA-2017-N-0763-0002", "FDA", "FDA-2017-N-0763", "010 Reference_09 AHRQ_2002_Systems to Rate the Scientific Evidence - 2002", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:11:37Z", null, 0, 0, "0900006482c13f9d"], ["FDA-2017-N-0763-0012", "FDA", "FDA-2017-N-0763", "Reference_19 Tormala_2006_Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:14:27Z", null, 0, 0, "0900006482c13fc5"], ["FDA-2017-N-0763-0050", "FDA", "FDA-2017-N-0763", "Reference_41 Sirtori_1979_Clinical experience with the soybean protein diet in the treatment of hypercholesterolemia", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:19:11Z", null, 0, 0, "0900006482c1401d"], ["FDA-2017-N-0763-0045", "FDA", "FDA-2017-N-0763", "Reference_46 Lovati_1987_Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:19:10Z", null, 0, 0, "0900006482c14022"], ["FDA-2017-N-0763-0195", "FDA", "FDA-2017-N-0763", "Reference_196 Hori_2001_Soy protein hydrolyzate with bound phospholipids reduces serum cholesterol levels", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:06:06Z", null, 0, 0, "0900006482c14940"], ["FDA-2017-N-0763-0192", "FDA", "FDA-2017-N-0763", "Reference_199_West_2005_Effects of including soy protein in a blood cholesterol-lowering diet on markers", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:06:06Z", null, 0, 0, "0900006482c1496a"], ["FDA-2017-N-0763-0219", "FDA", "FDA-2017-N-0763", "Reference_212 He_2005_Effect of soybean protein on blood pressure-a randomized, controlled trial", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:09:54Z", null, 0, 0, "0900006482c149bb"], ["FDA-2017-N-0763-0054", "FDA", "FDA-2017-N-0763", "Reference_57_Vessby_1982_The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy-protein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:22:32Z", null, 0, 0, "0900006482c1407b"], ["FDA-2017-N-0763-0070", "FDA", "FDA-2017-N-0763", "Reference_61 Bonanome_1988_Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:37Z", null, 0, 0, "0900006482c1407f"], ["FDA-2017-N-0763-0069", "FDA", "FDA-2017-N-0763", "Reference_62 Tabibi_2010_Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:37Z", null, 0, 0, "0900006482c14080"], ["FDA-2017-N-0763-0027", "FDA", "FDA-2017-N-0763", "Reference_24 Vega-Lopez_2005-Plasma antioxidant capacity in response to diets high in soy", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:15:41Z", null, 0, 0, "0900006482c14213"], ["FDA-2017-N-0763-0062", "FDA", "FDA-2017-N-0763", "Reference_69 Stephenson_2005_Effect of soy protein-rich diet on renal function in young adults", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:35Z", null, 0, 0, "0900006482c14287"], ["FDA-2017-N-0763-0100", "FDA", "FDA-2017-N-0763", "Reference_91 Anderson_2005_Weight loss and lipid changes with low-energy diets-comparator study", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:28Z", null, 0, 0, "0900006482c143b1"], ["FDA-2017-N-0763-0097", "FDA", "FDA-2017-N-0763", "Reference_94 Deibert_2004_Weight loss without losing muscle mass in pre-obese and obese subjects", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:27Z", null, 0, 0, "0900006482c143b4"], ["FDA-2017-N-0763-0177", "FDA", "FDA-2017-N-0763", "Reference_174 Mangano-2013-Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:03:26Z", null, 0, 0, "0900006482c144f0"], ["FDA-2017-N-0763-0132", "FDA", "FDA-2017-N-0763", "Reference_139 D'Amico_1991_Effect of dietary proteins and lipids in patients with membranous nephropathy", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:07Z", null, 0, 0, "0900006482c146a5"], ["FDA-2017-N-0763-0150", "FDA", "FDA-2017-N-0763", "Reference_141 Li_2005_Long-term efficacy of soy-based meal replacements vs and individualized diet plan in obese type", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:21Z", null, 0, 0, "0900006482c146a7"], ["FDA-2017-N-0763-0149", "FDA", "FDA-2017-N-0763", "Reference_142 Chiechi_2002_The effects of a soy rich diet on serum lipids-the menfis randomized trial", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:20Z", null, 0, 0, "0900006482c146a8"], ["FDA-2017-N-0763-0191", "FDA", "FDA-2017-N-0763", "Reference_180 Murkies_Dietary flour supplmentation decreases post-menopausal hot flushes", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:04:32Z", null, 0, 0, "0900006482c1491b"], ["FDA-2017-N-0763-0183", "FDA", "FDA-2017-N-0763", "Reference_188 Hoie_2006_Ultra heat treatment destroys cholesterol-lowering effect of soy protein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:04:30Z", null, 0, 0, "0900006482c1492f"], ["FDA-2017-N-0763-0206", "FDA", "FDA-2017-N-0763", "Reference_205 Desroches_2004_Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:07:44Z", null, 0, 0, "0900006482c14970"], ["FDA-2017-N-0763-0204", "FDA", "FDA-2017-N-0763", "Reference_207 Gardner_2007_Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:07:44Z", null, 0, 0, "0900006482c14972"], ["FDA-2017-N-0763-0021", "FDA", "FDA-2017-N-0763", "Reference_10 IOM DRIs for Dietary Fats, Chapter 8", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:14:28Z", null, 0, 0, "0900006482c13f9e"], ["FDA-2017-N-0763-0013", "FDA", "FDA-2017-N-0763", "Reference_18 Siefker_2006_Safety and antioxidant effects of a modest soy protein intervention in hemodialysis patients", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:14:27Z", null, 0, 0, "0900006482c13fc4"], ["FDA-2017-N-0763-0080", "FDA", "FDA-2017-N-0763", "Reference_71 Thorp_2008_Soy food consumption does not lower LDL cholesterol in either equol or nonequol producers", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:39:25Z", null, 0, 0, "0900006482c14289"], ["FDA-2017-N-0763-0072", "FDA", "FDA-2017-N-0763", "Reference_79 Ashton_Effects of soy as tofu vs meat on lipoprotein concentrations", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:39:23Z", null, 0, 0, "0900006482c142ac"], ["FDA-2017-N-0763-0089", "FDA", "FDA-2017-N-0763", "Reference_82 Duane_Effects of soybean protein and very low dietary cholesterol on serum lipids, biliary lipids", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:43:46Z", null, 0, 0, "0900006482c142af"], ["FDA-2017-N-0763-0087", "FDA", "FDA-2017-N-0763", "Reference_84 Hermansen_2005_Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:43:46Z", null, 0, 0, "0900006482c142b1"], ["FDA-2017-N-0763-0108", "FDA", "FDA-2017-N-0763", "Reference_103 Sirtori_1985_Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:31Z", null, 0, 0, "0900006482c143f5"], ["FDA-2017-N-0763-0123", "FDA", "FDA-2017-N-0763", "Reference_128 Soroka_ 1998_Comparison of a vegetable-based (soya) and an animal-based low-protein diet", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:26Z", null, 0, 0, "0900006482c14457"], ["FDA-2017-N-0763-0140", "FDA", "FDA-2017-N-0763", "Reference_131 Jenkins_2002_A dietary portfolio approach to cholesterol reduction-combined effects of plant sterols", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:09Z", null, 0, 0, "0900006482c14473"], ["FDA-2017-N-0763-0144", "FDA", "FDA-2017-N-0763", "Reference_147 Cicero_2002_Effects of a new soy_beta-sitosterol supplement on plasma lipids in moderately", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:19Z", null, 0, 0, "0900006482c144b7"], ["FDA-2017-N-0763-0164", "FDA", "FDA-2017-N-0763", "Reference_167 Teixeira_2004_Isolated soy protein consumption reduces urinary albumin excretion and improves the serum", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:02:07Z", null, 0, 0, "0900006482c144e9"], ["FDA-2017-N-0763-0175", "FDA", "FDA-2017-N-0763", "Reference_176 Bakhit_1994_Intake of 25 g of soybean protein  with or without soybean fiber alters plasma lipids", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:03:25Z", null, 0, 0, "0900006482c144f2"], ["FDA-2017-N-0763-0105", "FDA", "FDA-2017-N-0763", "Reference_106 Carroll_1978_Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:30Z", null, 0, 0, "0900006482c145e6"], ["FDA-2017-N-0763-0103", "FDA", "FDA-2017-N-0763", "Reference_108 Sacks_1983_Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:30Z", null, 0, 0, "0900006482c145e8"], ["FDA-2017-N-0763-0148", "FDA", "FDA-2017-N-0763", "Reference_143 Chiechi_2002_Efficacy of a soy rich diet in preventing postmenopausal osteoporosis", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:59:20Z", null, 0, 0, "0900006482c146a9"], ["FDA-2017-N-0763-0009", "FDA", "FDA-2017-N-0763", "Reference_02 Balk_2005_ Effects of soy on health Outcomes", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:11:40Z", null, 0, 0, "0900006482c13f96"], ["FDA-2017-N-0763-0187", "FDA", "FDA-2017-N-0763", "Reference_184 Greany_2004_Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:04:31Z", null, 0, 0, "0900006482c1491f"], ["FDA-2017-N-0763-0208", "FDA", "FDA-2017-N-0763", "Reference_203 Lichtenstein_2002_Lipoprotein response to diets high in soy or animal protein with and without isoflavones", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:07:45Z", null, 0, 0, "0900006482c1496e"], ["FDA-2017-N-0763-0217", "FDA", "FDA-2017-N-0763", "215 Reference_214 Chan_2007_Isoflavone intake in persons at high risk of cardiovascular events-implications for vascular", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:09:53Z", null, 0, 0, "0900006482c149bd"], ["FDA-2017-N-0763-0046", "FDA", "FDA-2017-N-0763", "Reference_45 Gardner-Thorpe_2003_Dietary supplements of soya flour lowers serum testosterone concentrations", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:19:10Z", null, 0, 0, "0900006482c14021"], ["FDA-2017-N-0763-0022", "FDA", "FDA-2017-N-0763", "Reference_29 Gallagher_2004_The effect of soy protein isolate on bone metabolism", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:15:39Z", null, 0, 0, "0900006482c13ff6"], ["FDA-2017-N-0763-0038", "FDA", "FDA-2017-N-0763", "Reference_33 Merz-Demlow_2000_Soy isoflavones improve plasma lipids in normocholesterolemic", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:16:45Z", null, 0, 0, "0900006482c13ffa"], ["FDA-2017-N-0763-0055", "FDA", "FDA-2017-N-0763", "Reference_56 Fumagalli_1982_Fecal cholesterol excretion studies in type II hypercholesterolemic patients", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:22:32Z", null, 0, 0, "0900006482c1407a"], ["FDA-2017-N-0763-0061", "FDA", "FDA-2017-N-0763", "Reference_50 Borodin_2009_Effects of two-month consumption of 30 g a day of soy protein isolate or skimmed curd protein", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:22:34Z", null, 0, 0, "0900006482c14239"], ["FDA-2017-N-0763-0076", "FDA", "FDA-2017-N-0763", "Reference_75 Ridges_2001_Cholesterol lowering benefits of soy and linseed enriched foods", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:39:24Z", null, 0, 0, "0900006482c142a8"], ["FDA-2017-N-0763-0096", "FDA", "FDA-2017-N-0763", "Reference_95 Puska_2002_Soy in hypercholesterolaemia_ a double-blind, placebo-controlled trial", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:27Z", null, 0, 0, "0900006482c143ed"], ["FDA-2017-N-0763-0094", "FDA", "FDA-2017-N-0763", "Reference_97 Allison_2003_A novel soy-based meal replacement formula for weight loss among obese individuals", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:46:26Z", null, 0, 0, "0900006482c143ef"], ["FDA-2017-N-0763-0107", "FDA", "FDA-2017-N-0763", "Reference_104 Sirtori_1999_Double-blind study of the addition of high-protein soya milk v. cows' milk to the diet", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:48:31Z", null, 0, 0, "0900006482c143f6"], ["FDA-2017-N-0763-0122", "FDA", "FDA-2017-N-0763", "Reference_129 Shige_199_-Effects of soy protein isolate (SPI) and casein on the postprandial lipemia", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:26Z", null, 0, 0, "0900006482c14458"], ["FDA-2017-N-0763-0139", "FDA", "FDA-2017-N-0763", "Reference_132 Jenkins_2000_The effect on serum lipids and oxidized low-density lipoprotein of supplementing", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:09Z", null, 0, 0, "0900006482c14474"], ["FDA-2017-N-0763-0163", "FDA", "FDA-2017-N-0763", "Reference_168 Murray_2003_Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:02:06Z", null, 0, 0, "0900006482c144ea"], ["FDA-2017-N-0763-0167", "FDA", "FDA-2017-N-0763", "Reference_164 Kohno_2006_Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:02:07Z", null, 0, 0, "0900006482c146b9"], ["FDA-2017-N-0763-0231", "FDA", "FDA-2017-N-0763", "Reference_220 Rosell_2004_Soy intake and blood cholesterol concentrations-a cross-sectional study", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:10:50Z", null, 0, 0, "0900006482c146d9"], ["FDA-2017-N-0763-0227", "FDA", "FDA-2017-N-0763", "Reference_224 Zhang_2003_Soy food consumption is associated with lower risk of coronary heart disease in Chinese", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T17:10:49Z", null, 0, 0, "0900006482c146dd"], ["FDA-2017-N-0763-0068", "FDA", "FDA-2017-N-0763", "Reference_63 St-Onge_2007_Supplementation with soy-protein-rich foods does not enhance weight loss", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:37Z", null, 0, 0, "0900006482c14081"], ["FDA-2017-N-0763-0058", "FDA", "FDA-2017-N-0763", "Reference_53 Campbell_2006_Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:22:33Z", null, 0, 0, "0900006482c1423f"], ["FDA-2017-N-0763-0064", "FDA", "FDA-2017-N-0763", "Reference_67 Pipe_2009_Soy protein reduces serum LDL cholesterol", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:33:36Z", null, 0, 0, "0900006482c14285"], ["FDA-2017-N-0763-0130", "FDA", "FDA-2017-N-0763", "Reference_121 Huff_1984_Turnover of very low-density lipoprotein-apoprotein b is increased by substitution", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:28Z", null, 0, 0, "0900006482c14450"], ["FDA-2017-N-0763-0126", "FDA", "FDA-2017-N-0763", "Reference_125_D'Amico_1992_Effect of dietary manipulation on the lipid abnormalities and urinary protein loss", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:55:27Z", null, 0, 0, "0900006482c14454"], ["FDA-2017-N-0763-0138", "FDA", "FDA-2017-N-0763", "Reference_133 Jenkins_2000_Effect of soy protein foods on low-denisty lipoprotein oxidation and ex vivo", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:09Z", null, 0, 0, "0900006482c14475"], ["FDA-2017-N-0763-0135", "FDA", "FDA-2017-N-0763", "Reference_136 Yamashita_1998_Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women", "Supporting & Related Material", "Background Material", "2017-10-31T04:00:00Z", 2017, 10, null, null, "2017-10-31T16:58:08Z", null, 0, 0, "0900006482c14478"]], "truncated": false, "filtered_table_rows_count": 235, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2017-N-0763"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763", "results": [{"value": "FDA", "label": "FDA", "count": 235, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-0763", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 231, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763", "results": [{"value": 2017, "label": 2017, "count": 232, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&posted_year=2017", "selected": false}, {"value": 2018, "label": 2018, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&posted_year=2018", "selected": false}, {"value": 2019, "label": 2019, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&posted_year=2019", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_facet_date=last_modified"}], "next": "2017-10-31T04~3A00~3A00Z,FDA-2017-N-0763-0135", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2017-N-0763&_next=2017-10-31T04~3A00~3A00Z%2CFDA-2017-N-0763-0135&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 834.0562039520591, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}